Trial Watch Edition 9 is live.
This edition tracks 15 high signal clinical trial events from May 1 to May 15, 2026, across oncology, cardiometabolic disease, immunology, and neurology.
ADC competition is intensifying in oncology.
Cardiometabolic programs are scaling across Lp(a), obesity, and comorbidity focused development.
Selective immunology and neurology programs continue to push toward sharper, higher conviction clinical readouts.
At KITSA, Trial Watch is our ongoing clinical intelligence series tracking where medicine is being built, one development window at a time.
